Amy Fisco, M.D.
Endocrinology, Diabetes & Metabolism Physician in Mount Pleasant, Wisconsin.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Amy Fisco, M.D. reported a CMS MIPS final score of 82.4/100 - below the 83.1 national average - and filed 4,711 Medicare Part D claims in 2023.
- 82.4/100
- MIPS score · -1 vs avg
- 5K
- Part D claims, 2023
- 47%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Amy Fisco, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
82 39th percentile higher than 39% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Amy Fisco, M.D. sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,521 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Amy Fisco, M.D. writes more Part D claims than 77% of them and scores higher on MIPS quality than 43% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Amy Fisco, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Amy Fisco, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Amy Fisco, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Wisconsin
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Wisconsin providers
Endocrinology, Diabetes & Metabolism Physician ranks #82 among Wisconsin's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Wisconsin provider total, by primary NUCC taxonomy. The highlighted bar is Endocrinology, Diabetes & Metabolism Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Amy Fisco, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 82.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 82.4/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
82.4/100 MIPS final score - 0.7 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Endocrinology, Diabetes & Metabolism Physician. Quality dim: 77.9. Cost dim: 74.4.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Amy Fisco, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 3805A SPRING ST, Mount Pleasant, WI, 53405, with a listed phone of (262) 687-8115. NPI 1346467958 was issued on 04/18/2007.
Medicare Part D records for calendar year 2023 show 4,711 prescription claims written by this provider, covering 421 Medicare beneficiaries and totaling roughly $2.2 million in drug spend, split 47% brand-name and 47% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.4/100 for the 2023 performance year (Quality 77.9, Cost 74.4), compared with the national average of 83.1.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1346467958 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 04/18/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Amy Fisco, M.D.'s current license status, disciplinary history, and board certifications with the Wisconsin Department of Safety and Professional Services in Wisconsin before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1346467958 is the unique 10-digit identifier CMS uses to link Fisco across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Amy Fisco, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Amy Fisco, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$202
Largest payer
Insulet Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
47% brand-name claims vs 47% generic, on 4,711 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 10,330
- Total Day Supply
- 304,318
- Brand vs Generic
- 47% brand / 47% generic
- Brand Drug Cost
- $2.1M
- Generic Drug Cost
- $45K
Patient Demographics
- Average Patient Age
- 69.8 years
- Avg HCC Risk Score
- 1.76
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 84, 65-74: 207, 75-84: 117, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Amy Fisco, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
698 claims
- Ozempic
Ozempic
285 claims
- Glimepiride 255
Glimepiride
255 claims
- Trulicity 243
Trulicity
243 claims
- Metformin Hcl 240
Metformin Hcl
240 claims
- Atorvastatin Calcium 232
Atorvastatin Calcium
232 claims
- Rosuvastatin Calcium 184
Rosuvastatin Calcium
184 claims
- Metformin Hcl Er 179
Metformin Hcl Er
179 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 698 |
| Ozempic Semaglutide | 285 |
| Glimepiride | 255 |
| Trulicity Dulaglutide | 243 |
| Metformin Hcl | 240 |
| Atorvastatin Calcium | 232 |
| Rosuvastatin Calcium | 184 |
| Metformin Hcl Er Metformin Hcl | 179 |
| Methimazole | 129 |
| Lisinopril | 125 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How Amy Fisco, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
Amy Fisco, M.D.'s 4,711 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Wisconsin
Other clinicians with the same primary specialty enrolled in Wisconsin, drawn from the same CMS NPPES roster as Fisco.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Wisconsin medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Wisconsin
Frequently Asked Questions
What is Amy Fisco, M.D.'s specialty? ▼
How much does Amy Fisco, M.D. prescribe under Medicare Part D? ▼
What is Amy Fisco, M.D.'s Medicare quality score? ▼
Where is Amy Fisco, M.D. located? ▼
What is Amy Fisco, M.D.'s NPI number? ▼
Does Amy Fisco, M.D. prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does Amy Fisco, M.D. prescribe most often? ▼
Does Amy Fisco, M.D. accept Medicare? ▼
How can I verify Amy Fisco, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology